Pharma Capital
Ian_55ae0ddd437b7.jpg

Big picture

Our Big Picture articles aim to explain and demystify, and answer one burning question: ‘Why should I invest?’ Updated regularly they give in-depth analysis of the company, its vision and attempt to assess its potential by tapping management and some of the City’s leading analysts. They are required reading for serious followers of the growth market.

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.